| Literature DB >> 35568849 |
Haleh Forouhandeh1, Zahra Rezaei Param2, Ommoleila Molavi3, Parina Asgharian4,5, Vahideh Tarhriz6.
Abstract
BACKGROUND: The genus Eryngium is a member of the Apiaceae family that has shown different pharmacological effects mainly including anti-inflammatory, analgesic, anti-cancer, hepatoprotective, and anti-oxidant. Previous research on the anti-cancer activity of Eryngium in some cancer cell lines has led us to explore the anti-proliferative activity of E. caucasicum in the B16F10 cell line.Entities:
Keywords: Apoptosis; Cytotoxicity; Eryngium caucasicum; Melanoma
Mesh:
Substances:
Year: 2022 PMID: 35568849 PMCID: PMC9107132 DOI: 10.1186/s12906-022-03618-w
Source DB: PubMed Journal: BMC Complement Med Ther ISSN: 2662-7671
Results were obtained from weighing n-Hex, DCM, and MeOH extracts and fractions from 200 g of E. caucasicum aerial powder
| MeOH | DCM | n-Hex | Extract | |||
|---|---|---|---|---|---|---|
| 3.18 | 2.12 | 3.68 | Weight of plant extract (g/100 g of extract) | |||
| Fractions | ||||||
| 6.7 | 10.35 | 12.05 | 13.01 | 5.5 | 1.1 | Weight of n-Hexane extract fractions (g/100 g of extract) |
IC50 values of extracts and fractions of the most effective extract on cancer cells (B16F10) after 24 and 48 hours in μg / mL
| IC50 (μg/ml) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| n-Hex | DCM | MeOH | 10% VlC fraction | 20% VlC fraction | 40% VlC fraction | 60% VlC fraction | 80% VlC fraction | 100% VlC fraction | |
| B16F10 24 h | 31.22 ± 2.7 | 47.59 ± 6.6 | 31.33 ± 20.7 | 23.87 ± 18.4 | 45.81 ± 28.2 | 39.83 ± 21.6 | |||
| B16F10 48 h | 24.77 ± 0.36 | 36.37 ± 5.7 | 48.57 ± 3.1 | 30.41 ± 4.1 | 33.41 ± 4.1 | 35.99 ± 3.8 | |||
Fig. 1Viability of B16F10 cancer cells after exposure to incremental concentrations of different fractions of the n-Hex extract of E. caucasicum using MTT method after 24 and 48 hours of incubation. *p < 0.05, **p < 0.01, and ***p < 0.001 indicate comparison treated groups with non-treated (Control) group
IC50 values of extracts and strong fractions on normal cells (HFFF2) after 24 hours in μg / mL
| IC50 (μg/ml) | |||
|---|---|---|---|
| Cell line | n-Hex extract | 40% VlC fraction of n-Hex extract | 60% VlC fraction of n-Hex extract |
| HFFF2 | 55.39 ± 0.28 | 19.79 ± 3.45 | 16.02 ± 5.2 |
Fig. 2Statistical comparison of B16F10 cell viability due to exposure to three types of n-Hex, MeOH, and DCM extracts after 24 and 48 hours of incubation compared with DMSO control group. *p < 0.05, **p < 0.01, and ***p < 0.001 indicate comparison treated groups with non-treated (Control) group
Fig. 3Viability of B16F10 cancer cells due to exposure to potent extract (n-Hex) and its fractions of E. caucasicum compared to normal HFFF2 cells − 2 in 24 hours. *p < 0.05, **p < 0.01, and ***p < 0.001 indicate comparison treated groups with control group
Fig. 4Flow cytometric test of effective extract and its potent fractions against B16F10 cell line and comparison of apoptotic and necrotic cells in B16F10 cell line
Fig. 5Comparison of apoptosis rates in B16F10 cell line after 24 hours